# EQT to acquire TachoSil biosurgery business from Corza Medical

EQT X agreed to acquire Corza Biosurgery, comprising the TachoSil hemostat and sealant patch business, from Corza Medical. The business employs approximately 400 people and manufactures at a facility in Linz, Austria.

- Type: Acquisition
- Announced: 2026-07-07
- Where: Linz, Austria, Austria
- Jobs: 400
- Status: announced
- Products: TachoSil hemostat and sealant patch
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [EQT](https://endata.com/companies/3219.md) (acquirer)
- [Corza Medical](https://endata.com/companies/52955.md) (target)
- [Corza Biosurgery](https://endata.com/companies/92895.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/eqt-to-acquire-the-tachosil-biosurgery-business-from-corza-medical-302819146.html), 2026-07-07: "EQT is pleased to announce that EQT X has agreed to acquire Corza Biosurgery from Corza Medical, comprising TachoSil, a leading dual-action active biologic patch."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.